One final under-$10 name that's trending near a big breakout is Synergy Pharmaceuticals (SGYP). This is a development-stage biopharmaceutical company focused primarily on the development of drugs to treat gastrointestinal disorders and diseases. This stock is off to a strong start in 2012 with shares up over 25% so far.
If you take a look at the chart for Synergy Pharmaceuticals, you'll notice that the sellers creamed this stock recently, after shares plunged from $7.08 to under $4.50 a share with heavy volume. That move resulted in gap down after it had broken out above $4.50 and made that huge run to $7.08 a share.Since that big gap lower, shares of Synergy Pharmaceuticals have been trending sideways for over a month between $4.13 and $4.95 a share. This sideways trend has resulted in very tight trading action, as this stock has coiled up right around both its 50-day at $4.48 and its 200-day at $4.40 a share. Traders should now look for long-biased trades in SGYP if it can manage to trigger a near-term breakout trade above $4.75 to $4.95 a share with high volume. Look for a sustained move or close above those levels on volume that's near or above its three-month average action of 238,000 shares. If we get that action soon, then SGYP could potentially fill that previous gap down and tag $6 to $7 a share. One could be a buyer of this stock off weakness and anticipate the breakout, and simply use a stop just below its 200-day moving average of $4.40 a share. Maybe use a stop at around $4.25 a share if you get long off weakness. You can also just wait for SGYP to take out $4.75 and then $4.95 with volume, and buy into that strength with a stop right around $4.60. On Wednesday, over 1 million shares traded for SGYP as the stock closed up modestly. That big-time volume indicates that large traders could be snapping up SGYP here, so keep this on your breakout radar. To see more hot under-$10 equities, check out the Stocks Under-$10 Setting Up to Explode portfolio on Stockpickr. -- Written by Roberto Pedone in Winderemere, Fla.
Twitter and become a fan on Facebook. This article is commentary by an independent contributor, separate from TheStreet's regular news coverage.
Select the service that is right for you!COMPARE ALL SERVICES
Jim Cramer and Stephanie Link actively manage a real portfolio and reveal their money management tactics while giving advanced notice before every trade.
- $2.5+ million portfolio
- Large-cap and dividend focus
- Intraday trade alerts from Cramer
- Weekly roundups
Access the tool that DOMINATES the Russell 2000 and the S&P 500.
- Buy, hold, or sell recommendations for over 4,300 stocks
- Unlimited research reports on your favorite stocks
- A custom stock screener
- Upgrade/downgrade alerts
Jim Cramer's protege, David Peltier, identifies the best of breed dividend stocks that will pay a reliable AND significant income stream.
- Diversified model portfolio of dividend stocks
- Alerts when market news affect the portfolio
- Bi-weekly updates with exact steps to take - BUY, HOLD, SELL
All of Real Money, plus 15 more of Wall Street's sharpest minds delivering actionable trading ideas, a comprehensive look at the market, and fundamental and technical analysis.
- Real Money + Doug Kass + 15 more Wall Street Pros
- Intraday commentary & news
- Ultra-actionable trading ideas
Our options trading pros provide daily market commentary and over 100 monthly option trading ideas and strategies to help you become a well-seasoned trader.
- 100+ monthly options trading ideas
- Actionable options commentary & news
- Real-time trading community
- Options TV